Menovo(SH:603538) Shang Hai Zheng Quan Bao·2026-01-05 20:56Core Viewpoint - The announcement details the conversion results of the convertible bonds issued by Ningbo Meinuo Pharmaceutical Co., Ltd., highlighting the amount converted into shares and the remaining unconverted bonds as of December 31, 2025 [2][7]. Summary by Sections Convertible Bond Issuance Overview - The company issued RMB 520 million in convertible bonds on January 14, 2021, with a maturity of six years and a tiered interest rate starting from 0.4% in the first year to 2.0% in the sixth year [3]. - The bonds began trading on February 4, 2021, under the name "Meinuo Convertible Bonds" with the code "113618" [3]. - The conversion price was set at RMB 37.47 per share starting from July 20, 2021 [3]. Conversion Status - As of December 31, 2025, a total of RMB 43,609,000 of "Meinuo Convertible Bonds" has been converted into 1,178,999 shares, representing 0.788% of the total shares outstanding before conversion [2][6]. - The amount of unconverted bonds as of the same date is RMB 476,391,000, which constitutes 91.614% of the total bonds issued [7]. Recent Conversion Activity - During the period from October 1, 2025, to December 31, 2025, the conversion amount was RMB 10,000, resulting in the issuance of 386 shares, which is 0.0003% of the total shares outstanding before conversion [6].